Net Loss Per Share (Details) - Schedule of dilutive shares - shares	3 Months Ended
Mar. 31, 2023	Mar. 31, 2022
Anti-dilutive shares	496,241,594	79,508,625
Convertible debt [Member]
Anti-dilutive shares	248,812,128	11,687,855
Stock options [Member]
Anti-dilutive shares	46,316,666	30,516,666
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	201,112,800	37,304,104

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration